Transient severe hypotension with once-weekly subcutaneous injection of teriparatide in osteoporotic patient: a case report and insight for the drug interaction between hypotensive agents and teriparatide-Reference-Cited by-同舟云学术

Transient severe hypotension with once-weekly subcutaneous injection of teriparatide in osteoporotic patient: a case report and insight for the drug interaction between hypotensive agents and teriparatide

Published:2015 Issue:1.2 Volume:62 Page:93-96
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Enishi Tetsuya¹,Uemura Hirokazu²,Katoh Shinsuke¹,Inatsugi Masanori³,Minato Sho³,Inatsugi Kei³,Inatsugi Mikiko³,Sato Nori¹,Siryo Koichi⁴

Affiliation:

1. Departments of Rehabilitation Medicine, The Tokushima University Hospital

2. Department of Preventive Medicine, Institute of Health Biosciences, University of Tokushima Graduate School

3. Departments of Orthopedics and Rehabilitation Medicine, The Inatsugi rehabilitation clinic

4. Departments of Orthopedics, The Tokushima University Hospital

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/62/1.2/62_93/_pdf

Reference14 articles.

1. 1. Okimoto N, Tsurukami H, Okazaki Y, Nishida S, Sakai A, Ohnishi H, Hori M, Yasukawa K, Nakamura T: Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats. Bone. 1998; 22(5): 523-31. Epub 1998/05/26. PubMed PMID: 9600787.

2. 2. Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y: Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. Journal of bone and mineral metabolism. 2004; 22(6): 569-76. Epub 2004/10/19. doi: 10.1007/s00774-004-0525-z. PubMed PMID: 15490267.

3. 3. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. The New England journal of medicine. 2001; 344(19): 1434-41. doi: 10.1056/NEJM200105103441904. PubMed PMID: 11346808.

4. 4. Tanaka S, Kuroda T, Sugimoto T, Nakamura T, Shiraki M: Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide. Current medical research and opinion. 2014. Epub 2014/01/08. doi: 10.1185/03007995.2013.879440. PubMed PMID: 24392946.

5. 5. Fujita T, Fukunaga M, Itabashi A, Tsutani K, Nakamura T: Once-Weekly Injection of Low-Dose Teriparatide (28.2 mug) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis. Calcified tissue international. 2014; 94(2): 170-5. Epub 2013/08/22. doi: 10.1007/s00223-013-9777-8. PubMed PMID: 23963633; PubMed Central PMCID: PMC3899450.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways;iScience;2023-10

2. Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study;Osteoporosis International;2019-08-08

3. Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study;Therapeutic Apheresis and Dialysis;2019-07-21

4. Beneficial effects of sulfonamide-based gallates on osteoblasts in vitro;Molecular Medicine Reports;2017-01-24

5. Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study;Osteoporosis International;2015-11-02